Stay updated on Eptinezumab Efficacy in Refractory Migraine Clinical Trial
Sign up to get notified when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.

Latest updates to the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page
- Check7 days agoChange DetectedThe record history now includes a new revision entry (v3.6.2) and removes the previous v3.6.0, updating the page's revision metadata.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe history now shows that recruitment for the study has ceased, indicating it is no longer enrolling participants. The record version has been updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.3%

- Check29 days agoChange DetectedA new revision entry, v3.5.5, supersedes the previous v3.5.4 in the page history, indicating an update to the record's metadata or formatting rather than the study details.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the record history, replacing the previous 'Revision: v3.5.3'. This update reflects a new version reference in the study's record history.SummaryDifference0.1%

- Check71 days agoChange DetectedThe update reflects a minor ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3) without changing the underlying study record information.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was deleted.SummaryDifference0.1%

Stay in the know with updates to Eptinezumab Efficacy in Refractory Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.